Home Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
Article
Licensed
Unlicensed Requires Authentication

Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?

  • Emmanuel J. Favaloro and Giuseppe Lippi
Published/Copyright: December 17, 2009

Abstract

The advent of modern instrumentation, with associated improvements in test performance and reliability, together with appropriate internal quality control (IQC) and external quality assurance (EQA) measures, has led to substantial reductions in analytical errors within hemostasis laboratories. Unfortunately, the reporting of incorrect or inappropriate test results still occurs, perhaps even as frequently as in the past. Many of these cases arise due to a variety of events largely outside the control of the laboratories performing the tests. These events are primarily preanalytical, related to sample collection and processing, but can also include post-analytical events related to the reporting and interpretation of test results. The current report provides an overview of these events, as well as guidance for prevention or minimization. In particular, we propose several strategies for the post-analytical reporting of hemostasis assays, and how this may provide the final opportunity to prevent serious clinical errors in diagnosis. This report should be of interest to both the laboratory scientists working in hemostasis and clinicians that request and attempt to interpret the test results. Laboratory scientists are ultimately responsible for these test results, and there is a duty to provide both accurate and precise results to enable clinicians to manage patients appropriately and to avoid the need to recollect and retest. Also, clinicians will not be in a position to best diagnose and manage their patient unless they gain an appreciation of these issues.

Clin Chem Lab Med 2010;48:309–21.


Corresponding author: Dr. Emmanuel J. Favaloro, Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, SWAHS, Westmead, NSW, 2145, Australia Phone: +612 9845 6618, Fax: +612 9689 2331,

Received: 2009-9-6
Accepted: 2009-10-15
Published Online: 2009-12-17
Published in Print: 2010-03-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Standardization of assays for clinically important enzymes that have high biologic variation: what is all the fuss about?
  3. Minireview
  4. Standardization in clinical enzymology: a challenge for the theory of metrological traceability
  5. Review
  6. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
  7. Opinion Paper
  8. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results
  9. Genetics and Molecular Diagnostics
  10. Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics
  11. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility
  12. Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
  13. Lack of association between DAZ gene methylation patterns and spermatogenic failure
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of five routine glucose methods on an Olympus AU5400 analyzer using the CDC hexokinase reference method
  16. Multicentre evaluation of the Tosoh HbA1c G8 analyser
  17. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting
  18. Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs
  19. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
  20. Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue
  21. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
  22. Composition of kidney stone fragments obtained after extracorporeal shock wave lithotripsy
  23. Reference Values and Biological Variations
  24. Gender does not influence cystatin C concentrations in healthy volunteers
  25. Stability of serum thyroid hormones following 8–11 years of cold storage
  26. Infectious Diseases
  27. Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR
  28. Letters to the Editor
  29. The polymorphisms –1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population
  30. Tissue factor +5466A>G and –1208D>I genetic polymorphisms and severity of rheumatoid arthritis
  31. Ability of deferasirox to bind iron during measurement of iron
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.061/pdf
Scroll to top button